Literature DB >> 15860354

Evidence for telomeric fusions as a mechanism for recurring structural aberrations of chromosome 11 in giant cell tumor of bone.

Jeffrey R Sawyer1, Linda S Goosen, Regina Lichti Binz, Charles M Swanson, Richard W Nicholas.   

Abstract

Giant cell tumor of bone (GCTB) is a benign but often aggressive tumor with a tendency toward local recurrence. Telomeric associations (tas) or telomeric fusions are common cytogenetic findings that have been implicated in the initiation of chromosome instability and tumorigenesis. We performed cytogenetic studies on 5 cases of GCTB to further characterize chromosome aberrations in these tumors. Four of the 5 cases showed abnormal karyotypes with clonal telomeric fusions involving chromosome 11. In 3 cases, the telomeric fusions of 11pter were apparently the precursor lesions to the progression of sub-clones with structural chromosome aberrations of 11p. Two tumors demonstrated a similar pattern of progression resulting in whole arm losses of 11p, including sub-clones with both whole-arm unbalanced translocations and whole-arm deletions. A third tumor with clonal tas of 11pter showed 2 additional subclones, one with ring chromosome 11 and the other with an extra copy of 1q. To our knowledge, the 2 cases with del(11)(p11) represent the first report of a recurring structural chromosome aberration in GCTB. These findings support the concept that telomeric instability is responsible for a large degree of intratumor heterogeneity and serves as a precursor lesion to subsequent clonal structural aberrations of chromosome 11 in GCTB.

Entities:  

Mesh:

Year:  2005        PMID: 15860354     DOI: 10.1016/j.cancergencyto.2004.09.001

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  7 in total

Review 1.  Giant cell tumour of bone: morphological, biological and histogenetical aspects.

Authors:  Mathias Werner
Journal:  Int Orthop       Date:  2006-09-30       Impact factor: 3.075

Review 2.  Prognosis of local recurrence in giant cell tumour of bone: what can we do?

Authors:  Yifeng He; Ji Zhang; Xiaoyi Ding
Journal:  Radiol Med       Date:  2017-03-07       Impact factor: 3.469

3.  Identification of potential biomarkers for giant cell tumor of bone using comparative proteomics analysis.

Authors:  Amalia Conti; Gemma Caballero Rodriguez; Antonella Chiechi; Rosa Maria Dégano Blazquez; Victoria Barbado; Tibor Krènacs; Chiara Novello; Laura Pazzaglia; Irene Quattrini; Licciana Zanella; Piero Picci; Enrique De Alava; Maria Serena Benassi
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

4.  Giant cell tumor of bone: a neoplasm or a reactive condition?

Authors:  Anwar Ul Haque; Ambreen Moatasim
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 5.  Centromere fission, not telomere erosion, triggers chromosomal instability in human carcinomas.

Authors:  Carlos Martínez-A; Karel H M van Wely
Journal:  Carcinogenesis       Date:  2011-04-08       Impact factor: 4.944

6.  Clinical and cytogenetic aspects of giant cell tumor of the sternum.

Authors:  Edgard Eduard Engel; Marcello Henrique Nogueira-Barbosa; Maurício Eiji de Almeida Santos Yamashita; Federico Enrique Garcia Cipriano; Elvis Terci Valera; Maria Sol Brassesco
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

7.  p63 regulates cell proliferation and cell cycle progression‑associated genes in stromal cells of giant cell tumor of the bone.

Authors:  Carol Po Ying Lau; Patrick Kwok Shing Ng; Man Shan Li; Stephen Kwok Wing Tsui; Lin Huang; Shekhar Madhukar Kumta
Journal:  Int J Oncol       Date:  2012-12-03       Impact factor: 5.650

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.